4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-068959
Chairman and CEO bought 6,600 shares at an average $1.58 ($10,456)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-12-06 | Purchase | +1,500 | $1.49 | $2,235 | 11,091,706 | D |
| Niihara Yutaka Chairman and CEO | 2021-12-07 | Purchase | +1,900 | $1.55 | $2,945 | 11,093,606 | D |
| Niihara Yutaka Chairman and CEO | 2021-12-08 | Purchase | +1,200 | $1.58 | $1,896 | 11,094,806 | D |
| Niihara Yutaka Chairman and CEO | 2021-12-09 | Purchase | +2,000 | $1.69 | $3,380 | 11,096,806 | D |
| Open-market purchases · 6,600 sh · avg $1.58 · $10,456 | |||||||
Loading xslF345X03/doc4.xml…